Congress 60: An addiction recovery community within the Islamic republic of Iran

Alcoholism Treatment Quarterly

Volumn 33, Issue 3, 2015, Pages 328-347

  White, William L ^a  

^a Chestnut Health Systems   (United States)

Author keywords

Congress 60; DST Method; Hossein Dezhakam; Iran; opium tincture

Indexed keywords

ILLICIT DRUG; NARCOTIC AGENT;

ADDICTION; ALCOHOLICS ANONYMOUS; ARTICLE; DRUG BIOAVAILABILITY; DRUG DEPENDENCE; FINANCIAL MANAGEMENT; HUMAN; IRAN; MARKETING; OPIATE ADDICTION; REHABILITATION CENTER; TOBACCO DEPENDENCE;

EID: 84937391084     PISSN: 07347324     EISSN: 15444538     Source Type: Journal    
DOI: 10.1080/07347324.2015.1050929     Document Type: Article

References (91)

1. Afkhami, A. A. (2009). From punishment to harm reduction: Resecularization of addiction in contemporary Iran. In A. Gheissari (Ed.), Contemporary Iran: Economy, society, politics (pp. 194-210). Oxford, England: Oxford University Press.
2. Ahmadi, J. (2002). Buprenorphine maintenance treatment of heroin dependence: The first experience from Iran. Journal of Substance Abuse Treatment, 22(3), 157-159. doi:10.1016/S0740-5472(02)00222-2
3. Ahmadi, J., Arabi, H., & Mansouri, Y. (2003). Prevalence of substance use among offspring of opioid addicts. Addictive Behaviors, 28, 591-595. doi:10.1016/S0306-4603(01)00260-X
4. Ahmadi, J., Babaee-Beigi, M., Alishahi, M., Maany, I., & Hidari, T. (2004). Twelvemonth maintenance treatment of opium-dependent patients. Journal of Substance Abuse Treatment, 26, 6-64. doi:10.1016/S0740-5472(03)00141-7
5. Ahmadi, J., & Motamed, F. (2003). Treatment success rate among Iranian opioid dependents. Substance Use & Misuse, 38(1), 151-163. doi:10.1081/JA-120016571
6. Ahmadi, J., Pridmore, S., Alimi, A., Cheraghi, A., Arad, A., Parsaeyan, H., Kianpour, M. (2007). Epidemiology of opium use in the general population. American Journal of Drug and Alcohol Abuse, 33(3), 483-491. doi:10.1080/00952990701301293
7. Ali, R., Jittiwutikarn, J., Hall, J., White, J., Christie, P., Bochner, F., Gray, J. (2000). Tincture of opium and the use of heroin in Adelaide's Vietnamesecommunity (DASC Monograph No. 7 Research Series). Adelaide, Australia: Drug and Alcohol Services Council.
8. Aliverdinia, A., & Pridemore, W. A. (2008). An overview of the illicit narcotics problem in the Islamic Republic of Iran. European Journal of Crime, Criminal Law and Criminal Justice, 16, 155-170. doi:10.1163/157181708X308434
9. Ataee, M., Jouybari, A., Alavijeh, M. M., Aghaei, A., Mahboubi, M., & Motlagh, F. Z. (2014). Factors related with intention to methadone maintenance treatment among Iranian men addicts. Life Science Journal, 11(4s), 228-231.
10. Auriacombe, M., Grabot, D., Daulouède, J. P., Vergnolle, J. P., O'Brien, C., & Tignol, J. (1993). Alternatives to methadone maintenance: Laudanum, buprenorphine. In L. Harris (Ed.), Problems of drug dependence, 1992: Proceedings of the 54th Annual Scientific Meeting the College on Problems of Drug Dependence, Inc. research monograph 132 (p. 308). Rockville, MD: U.S. Department of Health and Human Services.
11. Auriacombe, M., Grabot, D., Daulouède, J.-P., Vergnolle, J.-P., O'Brien, C., & Tignol, J. (1994). A naturalistic follow-up study of French-speaking opiate-maintained heroin-addicted patients: Effects on biopsychosocial status. Journal of Substance Abuse Treatment, 11(6), 565-568. doi:10.1016/0740-5472(94)90008-6
12. Calabrese, J. (2007). Iran's war on drugs: Holding the line? The Middle East Institute, Policy Brief, 3, 1-18. Retrieved from http://www.mideasti.org/content/irnaswar-drugs-holding-line?pageD16
13. Chandrasena, R. (1980). Management of opium dependence in a general hospital psychiatry unit. British Journal of Addiction, 75(2), 163-167. doi:10.1111/j.1360-0443.1980.tb02441.x
14. Cloud, W., & Granfield, R. (2008). Conceptualizing recovery capital: Expansion of a theoretical construct. Substance Use and Misuse, 43(12/13), 1971-1986. doi:10.1080/10826080802289762
15. Dahmardehei, M., & Rafaiee, R. (2012). Opium syrup distribution, limitation and challenges. Zahedan Journal of Research in Medical Sciences, 16(6), 48.
16. Day, C., Nassirimanesh, B., Shakeshaft, A., & Dolan, K. (2006). Patterns of drug use among a sample of drug users and injecting drug users attending a general practice in Iran. Harm Reduction Journal, 3, 2. doi:10.1186/1477-7517-3-2
17. De Leon, G., Staines, G. L., Perlis, T. E., Sacks, S., McKendrick, K., Hilton, R., & Brady, R. (1995). Therapeutic community methods in methadone maintenance (Passages): An open clinical trial. Drug and Alcohol Dependence, 37, 45-57. doi:10.1016/0376-8716(94)01057-R
18. Dezhakam, H. (2011a). Crossing the zone 60 degrees below zero. Tehran, Iran: Congress 60.
19. Dezhakam, H. (2011b). Love: Fourteen valleys for recovery. Tehran, Iran: Congress 60.
20. Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., Allsop, D., & Mokri, A. (2011). Characteristics of Iranian women seeking drug treatment. Journal of Women's Health, 20(11), 1687-1691. doi:10.1089/jwh.2010.2694
21. Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., & Mokri, A. (2011). The establishment of a methadone treatment clinic for women in Tehran, Iran. Journal of Public Health Policy, 32, 219-230. doi:10.1057/jphp.2011.10
22. Dole, V. P., & Nyswander, M. E. (1967). Heroin addiction-a metabolic disease. Archives of Internal Medicine, 120, 19-24. doi:10.1001/archinte.1967.00300010021004
23. Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966). Narcotic blockade. Archives of Internal Medicine, 118, 304-309. doi:10.1001/archinte.1966.00290160004002
24. Eskandarieh, S., Nikfarjam, A., Tarjoman, T., Nasehi, A., Jafari, F., & Saberi-Zafarghandi, M.-B. (2013). Descriptive aspects of injection drug users in Iran's national harm reduction program by methadone maintenance treatment. Iran Journal of Public Health, 42(6), 588-593.
25. Esmaeli, H.-R., Ziaddinni, H., Nikravesh, M.-R., Baneshi, M.-R., & Nakhaee, N. (2014). Outcome evaluation of the opioid agonist maintenance treatment in Iran. Drug and Alcohol Review, 33(2), 186-193. doi:10.1111/dar.12112
26. Evans, A. C., White, W. L., & Lamb, R. (2013). The role of harm reduction in recoveryoriented systems of care: The Philadelphia experience. Philadelphia, PA: Department of Behavioral Health and Intellectual disAbility Services. Retrieved from http://www.williamwhitepapers.com/pr/Recovery%20and%20Harm%20Reduction%20In%20Philadelphia.pdf (Accessed June 15, 2015)
27. Farnam, R. (2005). Substance abuse in Iran: A brief overview. Retrieved from http://uclaisap.org/slides/dssat2005/Farnam.pdf
28. Farnia, M., Ebrahimi, E., Shams, A., & Zamani, S. (2010). Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran. International Journal of Drug Policy, 21, 422-424. doi:10.1016/j.drugpo.2010.03.008
29. Fathi, N. (2008, June 27). Iran fights scourge of addiction in plain view, stressing treatment. New York Times. Retrieved from http://www.nytimes.com/2008/06/27/world/middleeast/27addiction.html?pagewantedDall&-rD0
30. Figg-Franzoi, L. (2011). Maslahat, the state and the people: Opium use in the Islamic Republic of Iran. Crime, Law and Social Change, 56(4), 421-438. doi:10.1007/s10611-011-9326-1
31. Ghanizadeh, A., Ashkani, H., & Maany, I. (2000). Comorbidity of psychiatric disorders in Iranian treatment-seeking opioid addicts. Iranian Journal of Medical Sciences, 25(1 & 2), 25-30.
32. Gruber, V. A., Delucchi, K. L., Kielestein, A., & Batiki, S. L. (2008). A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug and Alcohol Dependence, 94, 199-206. doi:10.1016/j.drugalcdep.2007.11.021
33. Iranian National Center for Addiction Studies. (2007). Iranian National Center for Addiction Studies. Iranian Journal of Psychiatry and Behavioral Sciences, 1(1), 41-42.
34. Jittiwutikarn, J., Ali, R., White, J. M., Bochner, F., Somogyi, A. A., & Foster, D. J. R. (2004). Comparison of oral tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre. British Journal of Clinical Pharmacology, 58(5), 536-541. doi:10.1111/j.1365-2125.2004.02209.x
35. Kellogg, S. H. (2003). On "gradualism" and the building of the harm reduction-abstinence continuum. Journal of Substance Abuse Treatment, 25, 241-247. doi:10.1016/S0740-5472(03)00068-0
36. Kobra, L., Mohammad, B. N., & Alireza, S. S. (2012). Quality of life in patients on methadone maintenance treatment: A three-month assessment. Journal of the Pakistan Medical Association, 62, 1003-1007.
37. Koob, G. F. (2009). Dynamics of neuronal circuits in addiction: Reward, antireward, and emotional memory. Pharmacopsychiatry, 42, S32-S41. doi:10.1055/s-0029-1216356
38. Kreek, M. J. (2000). Methadone-related opioid agonist pharmacotherapy for heroin addiction: History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Sciences, 909, 186-216. doi:10.1111/j.1749-6632.2000.tb06683.x
39. Kreek, M. J. (2010). Overview and historical perspective of four papers presented on research related to the endogenous opioid system. Drug and Alcohol Dependence, 108, 195-199. doi:10.1016/j.drugalcdep.2010.03.003
40. Lavitt, J. (2014). The crescent and the needle: The remarkable rise of NA in Iran. Retrieved from http://www.thefix.com/content/Iran-Narcotics-Anonymous-phonemoneon-Lavitt2099?pageDall
41. Maarefvand, M., Ghiasvand, H. R., & Ekhtiari, H. (2013). Drug craving terminology among opiate dependents: A mixed method study. Iranian Journal of Psychiatry, 8(2), 97-103.
42. Maltais, K. (2011). 20,000 Iranian addicts gather to celebrate recovery. Retrieved from http://www.thefix.com/content/200000-iranian-addicts-gather-celebraterecovery
43. Marlatt, G. A., Blume, A. W., & Parks, G. A. (2001). Integrating harm reduction therapy and traditional substance abuse treatment. Journal of Psychoactive Drugs, 33(1), 13-21. doi:10.1080/02791072.2001.10400463
44. Matthee, R. (2005). The pursuit of pleasure: Drugs and stimulants in Iranian history, 1500-1900. Princeton, NJ: Princeton University Press.
45. McLellan, A. T., Hagan, T. A., Levine, M., Gould, F., Meyers, K., Bencivengo, M., & Durell, J. (1998). Supplemental social services improve outcomes in public addiction treatment. Addiction, 93(10), 1489-1499. doi:10.1046/j.1360-0443.1998.931014895.x
46. McLellan, A. T., Woody, G. E., Luborsky, L., & Goehl, L. (1988). Is the counselor an 'active ingredient' in substance abuse rehabilitation? An examination of treatment success among four counselors. Journal of Nervous and Mental Disease, 176, 423-430.
47. Mehrjerdi, Z. A. (2013). Crystal in Iran: Methamphetamine or heroin kerack. DARU Journal of Pharmaceutical Sciences, 21, 22. doi:10.1186/2008-2231-21-22
48. Mehrjerdi, Z. A., & Zarghami, M. (2013).Maintenance therapy with opium tincture for injecting drug users: Implications for prevention from viral infections. Hepatitis Monthly, 13(4), E8334. doi:10.5812/hepatmon.8334
49. Mirlashari, J., Demirkol, A., Salsali, M., Rafiey, H., & Jahahbani, J. (2012). Early childhood experiences, parenting and the process of drug dependency among young people in Tehran, Iran. Drug and Alcohol Review, 31(4), 461-468. doi:10.1111/j.1465.3362.2011.00384.x
50. Moeni, M., Razzaghi, O. M., Mahmood, M., & Pashaeie, T. (2014). Analysis of retention among a sample of opioid dependents participating in the Methadone Maintenance Treatment Program in Iran. Journal of the School of Public Health and Institute of Public Health Research, 11(3), 55-64.
51. Mohammad, K. A., Hassan, S., & Dariush, B. (2011). Crack in Iran: Is it really cocaine? Journal of Addiction Research & Therapy, 2, 107. doi:10.4172/2155-6105.1000107
52. Mohammad, K. (2007, March 25). Iran's in a fix. The Daily Mail (London).
53. Mohammadpoorasl, A., Fakhari, A., Akbari, H., Karimi, F., Bostanabad, M. A., Rostami, F., & Hajizadeh, M. (2012). Addiction relapse and its predictors: A prospective study. Journal of Addiction Research & Therapy, 3, 122. doi:10.4172/2155-6105.1000122
54. Mokri, A. (2002). Brief overview of the status of drug abuse in Iran. Archives of Iranian Medicine, 5(3), 184-190.
55. Movaghar, A. R., Langroodi, Z. M., Ahmadi, S. D., & Esmaeili, M. A. (2011). A qualitative study of specific needs of women for treatment of addiction. Iranian Journal of Psychiatry and Clinical Psychology, 17(2), 116-125.
56. Namdarpour, F., & Iravani, M. R. (2013). The survey study effect of feedback on the willingness of Holland's theory of interest the spouses of addicts, the quality of life. Journal of Social Issues & Humanities, 1(4), 45-48.
57. Narimani, M., & Sadeghieh, S. A. (2008). A study of the rate and causes of addiction relapse among volunteer addicts seeking help at the Center for the Prevention of Addiction affiliated to theWelfare Organization, Ardabil Province, Iran. Research Journal of Biological Sciences, 3(2), 258-264.
58. Nataparan, C. (2000). Methadone maintenance and harm reduction in Northern Thailand. Retrieved from http://www.drugtext.org/Opiates-heroin-methadone/methadone-maintenance-and-harm-reduction-in-northern-thailand.html
59. Rahimi-Movaghar, A., Hefazi, M., Davoli, M., Amato, L., Amin-Esmaeili, M., Sahimi-Izadian, E., & Yousefi-Nooraie, R. (2009). Pharmacological therapies for management of opium withdrawal. Cochrane Database of Systematic Reviews, 1, Art. No. CD007522. doi:10.1002/14651858.CD007522
60. Rahimi-Movaghar, A., Khastoo, G., Razzaghi, E., Saberi-Zafarghandi, M. B., Noroozi, A. R., & Jar-Siah, R. (2011b). Compulsory methadone maintenance treatment of severe cases of drug addiction in a residential setting in Tehran, Iran (1): Process evaluation. Payesh Health Monitor, 10(4), 493-503.
61. Rahimi-Movaghar, R., Khastoo, G., Razzaghi, E., Saberi-Zafarghandi, M. B., Norrozi, A. R., & Jar-Siah, R. (2011a). Compulsory methadone maintenance treatment of severe cases of drug addiction in a residential setting in Tehran, Iran: Outcome evaluation in two and six-month follow-up. Payesh Health Monitor, 10(4), 505-514.
62. Rahimi-Movaghar, R., Mohammad, K., & Razzaghi, E. M. (2002). Trend of drug abuse situation in Iran: A three-decade review. Hakim Research Journal, 5(3), 171-181.
63. Rahimpour, R., Khankeh, H. R., Khoshknab, M. F., Farhoodian, A., & Farzi, F. (2012). The evaluation of marital adjustment of the addicts in Isfahan NA groups and their couples. Iranian Rehabilitation Journal, 10(15), 13-17.
64. Razzaghi, E. M., Rahnimi, A., Hosseni, M., Madani, S., & Chaterjee, A. (1999). Rapid Situation Assessment (RSA) of drug abuse in Iran (1998-1999). Tehran, Iran: Ministry of Health, I.R. of Iran and United Nations International Drug Control Program State Welfare Organizations, Prevention Department.
65. Richards, I., & Henry-Edwards, S. (2002). Proceedings Workshop for Pharmacotherapies to Manage Opioid Dependence in Asia, Beijing, August 5-7. DASC Monograph No. 12 Research Series. Adelaide, Australia: Drug and Alcohol Services Council.
66. Roshani, B., Jalali, A., Bidhendi, S., Ezzati, E., & Mahboubi, M. (2014). Study the causes of relapse among Iranian drugs users in Kermanshah. Life Science Journal, 11(1s), 66-71.
67. Rouhani, S., Kheirkhak, F., Salarieh, I., & Abedi, S. (2012). Quality of life, its early change and retention in MMT programs in Iran: Evidence for policymakers and service providers. Life Science Journal, 9(3), 2633-2638.
68. Sadir, N., Shojaei, M., Moadab, K., Ababasi, R., Bahrampour, A., & Nakjhee, N. (2013). Outcome evaluation of therapeutic community model in Iran. International Journal of Health Policy Management, 1(2), 131-135.
69. Sayyah, S. (2006, June 8). Narcotics Anonymous in Iran. Payvand News of Iran. Retrieved from http://www.pavand.com.news/o6/jun/1070.html
70. Schwartz, R. P., Kelly, S. M., O'Grady, K. E., Gandhi, D., & Jaffe, J. H. (2011). Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Addiction, 107, 943-952. doi:10.1111/j.1360-0443.2011.03700.x
71. Shahrbabaki, M. E., Ziaaddini, H., Doost, A. A. H., Ghasemi, M., Shahrbabaki, P. E., Nouri, R. A., & Sharrbabaki, N. S. (2011). Methadone treatment in Iranian opiate addicts: A preliminary report. Addiction & Health, 3(1/2), 53-60.
72. Shariatirad, S., & Maarefvand, M. (2013). Sanctions against Iran and the impact on drug use and addiction treatment. International Journal of Drug Policy, 24(6), 636-637. doi:10.1016/j.drugpo.2013.04.003
73. Sharifi, H., Kharaghani, R., Sigari, S., Emami, H., Sadr, M., & Masjedi, M. R. (2012). Common methods to treat addiction in treatment-rehabilitation centers in Tehran. Iranian Journal of Public Health, 41(4), 63-68.
74. Shekarchizadeh, H., Ekhtiari, H., Khami, M. R., & Virtanen, J. I. (2012). Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance in Iran. Harm Reduction Journal, 9, 18. doi:10.1186/1477-7517-9-18
75. Somogyi, A. A., Larsen, M., Abadi, R. M., Jittiwutikarn, J., Ali, R., & White, J. M. (2008). Flexible dosing of tincture of opium in the management of opioid withdrawal: Pharmacokinetics and pharmacodynamics. British Journal of Pharmacodynamics, 66(5), 640-647. doi:10.1111/j.1365-2125.2008.03277.x
76. Sorensen, J. L., Andrews, S., Delucchi, K. L., Greenberg, B., Guydish, J., Masson, C. L., & Shopshire, M. (2009). Methadone patients in the therapeutic community: A test of equivalency. Drug and Alcohol Dependence, 100(1/2), 100-106. doi:10.1016/j.drugalcdep.2008.09.009
77. Tabatabaei-Jafari, H., Ekhtiari, H., Ganjgahi, H., Hassani-Abharian, P., Oghabian, M. A., Moradi, A, Zarei, M. (2014), Patterns of brain activation during craving in heroin dependents successfully treated by methadone maintenance and abstinence-based treatments. Journal of Addiction Medicine, 8(2), 123-129. doi:10.1097/ADM.0000000000000022
78. Tanner, I. (2013, August 23). The lion chases away the dragon: Iran's drug treatment programs are among the world's most progressive. The Majalla: The Leading Arab Magazine. Retrieved from http://www.majalla.com/eng/2013/08/article55244942.
79. Tavakoli, M. (2013). The influence of detoxification on the quality of life in substance addicts lives with 40-65 years of age referring to the charity Congress60. Iranian Journal of Ageing, 6(23), 3. Retrieved from http://www.yektawebsite.ir/-salmand/search.php?slc-langDen&sidD1&authDTavakoli
80. Tavakoli, M., Sahaf, R., Ghaffari, S., Farhoudian, A., & Hayatbakhsh, R. (2012). Cost benefit analysis of detoxification in addicts over 40 in human recovery population (Congress 60). Quarterly Journal of Rehabilitation, 12(5), 52-57.
81. Trigo, J. M., Martin-Garcia, E., Berrendero, F., Robledo, P., & Maldonado, R. (2010). The endogenous opioid system: A common substrate in drug addiction. Drug and Alcohol Dependence, 108, 183-194. doi:10.1016/j.drugalcdep.2009.10.011
82. White, W. L. (1996). Pathways from the culture of addiction to the culture of recovery. Center City, MN: Hazelden.
83. White, W. L. (1998). Slaying the dragon: The history of addiction treatment and recovery in America. Bloomington, IL: Chestnut Health Systems.
84. White, W. L. (2011). An addiction recovery community in the Islamic Republic of Iran: An interview with Mr. Hossein Dezhakam, founder, Congress60. Retrieved from http://www.williamwhitepapers.com/pr/2011%20Iran%20Mr%20Hossein%20Dezhakam.pdf
85. White, W. L. (2012a). Medication-assisted recovery from opioid addiction: Historical and contemporary perspectives Journal of Addictive Diseases, 31(3), 199-206. doi:10.1080/10550887.2012.694597
86. White, W. L. (2012b). Smoking cessation within a recovery community: An interview with Hossein Dezhakam, Congress60, Iran. Retrieved from http://www.williamwhitepapers.com/pr/2012%20Smoking%20Cessation%20in%20Congress60%20Hossein%20Dezhakam%2C%20Iran.pdf
87. White, W. L., Campbell, M. D., Spencer, R. A., Hoffman, H. A., Crissman, B., & DuPont, R. L. (2014). Participation in Narcotics Anonymous and Alcoholics Anonymous and abstinence outcomes of 322 methadone maintenance patients. Journal of Groups in Addiction and Recovery, 9(1), 14-30. doi:10.1080/1556035X.2014.888883
88. White, W. L., & Torres, L. (2010). Recovery-oriented methadone maintenance. Chicago, IL: Philadelphia Department of Behavioral Health and Intellectual disAbility Services and Northeast Addiction Technology Transfer Center, Great Lakes Addiction Technology Transfer Center.
89. Zamani, S., Kihara, M., Gouya, M., Vazirian, M., Nassirimanesh, B., Ono-Kihara, M., Icikawa, S. (2006). High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. Journal of Acquired Immune Deficiency Syndromes, 42(3), 342-346. doi:10.1097/01.qai.0000219785.81163.67
90. Zarrindast, M.-R., Sahraei, H., & Dejakam, H. (2010). New dimension in drug addiction therapy. Basic and Clinical Neuroscience, 1(4), 67-68.
91. Ziaaddini, H., & Ziaaddini, R. (2005). The household survey of drug abuse in Kerman, Iran. Journal of Applied Sciences, 5(2), 380-382.